|
1
|
Du K, Zhao C, Wang L, Wang Y, Zhang KZ,
Shen XY, Sun HX, Gao W and Lu X: MiR-191 inhibit angiogenesis after
acute ischemic stroke targeting VEZF1. Aging (Albany NY).
11:2762–2786. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen Z, Wang K, Huang J, Zheng G, Lv Y,
Luo N, Liang M and Huang L: Upregulated serum MiR-146b serves as a
biomarker for acute ischemic stroke. Cell Physiol Biochem.
45:397–405. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Marquez-Romero JM, Góngora-Rivera F,
Hernández-Curiel BC, Aburto-Murrieta Y, García-Cazares R,
Delgado-Garzón P, Murillo-Bonilla LM and Ochoa-Solórzano MA:
Endovascular treatment of ischemic stroke in a developing country.
Vasc Endovascular Surg: Feb 19, 2020 (Epub ahead of print).
|
|
4
|
Béjot Y, Daubail B and Giroud M:
Epidemiology of stroke and transient ischemic attacks: Current
knowledge and perspectives. Rev Neurol (Paris). 172:59–68.
2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cheng X, Kan P, Ma Z, Wang Y, Song W,
Huang C and Zhang B: Exploring the potential value of miR-148b-3p,
miR-151b and miR-27b-3p as biomarkers in acute ischemic stroke.
Biosci Rep. 38(38)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ji Q, Ji Y, Peng J, Zhou X, Chen X, Zhao
H, Xu T, Chen L and Xu Y: Increased brain-specific MiR-9 and
MiR-124 in the serum exosomes of acute ischemic stroke patients.
PLoS One. 11(e0163645)2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jia L, Hao F, Wang W and Qu Y: Circulating
miR-145 is associated with plasma high-sensitivity C-reactive
protein in acute ischemic stroke patients. Cell Biochem Funct.
33:314–319. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Jiang M, Wang H, Jin M, Yang X, Ji H,
Jiang Y, Zhang H, Wu F, Wu G, Lai X, et al: Exosomes from
MiR-30d-5p-ADSCs reverse acute ischemic stroke-induced,
autophagy-mediated brain injury by promoting M2
microglial/macrophage polarization. Cell Physiol Biochem.
47:864–878. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Jin F and Xing J: Circulating miR-126 and
miR-130a levels correlate with lower disease risk, disease
severity, and reduced inflammatory cytokine levels in acute
ischemic stroke patients. Neurol Sci. 39:1757–1765. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Khanna S, Rink C, Ghoorkhanian R, Gnyawali
S, Heigel M, Wijesinghe DS, Chalfant CE, Chan YC, Banerjee J, Huang
Y, et al: Loss of miR-29b following acute ischemic stroke
contributes to neural cell death and infarct size. J Cereb Blood
Flow Metab. 33:1197–1206. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li SH, Chen L, Pang XM, Su SY, Zhou X,
Chen CY, Huang LG, Li JP and Liu JL: Decreased miR-146a expression
in acute ischemic stroke directly targets the Fbxl10 mRNA and is
involved in modulating apoptosis. Neurochem Int. 107:156–167.
2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Su ZF, Sun ZW, Zhang Y, Wang S, Yu QG and
Wu ZB: Regulatory effects of miR-146a/b on the function of
endothelial progenitor cells in acute ischemic stroke in mice.
Kaohsiung J Med Sci. 33:369–378. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tiedt S, Prestel M, Malik R,
Schieferdecker N, Duering M, Kautzky V, Stoycheva I, Böck J,
Northoff BH, Klein M, et al: RNA-Seq identifies circulating
miR-125a-5p, miR-125b-5p, and miR-143-3p as potential biomarkers
for acute ischemic stroke. Circ Res. 121:970–980. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang Y, Zhang Y, Huang J, Chen X, Gu X,
Wang Y, Zeng L and Yang GY: Increase of circulating miR-223 and
insulin-like growth factor-1 is associated with the pathogenesis of
acute ischemic stroke in patients. BMC Neurol.
14(77)2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wu J, Du K and Lu X: Elevated expressions
of serum miR-15a, miR-16, and miR-17-5p are associated with acute
ischemic stroke. Int J Clin Exp Med. 8:21071–21079. 2015.PubMed/NCBI
|
|
16
|
Zhang J, Liu W, Wang Y, Zhao S and Chang
N: miR-135b plays a neuroprotective role by targeting GSK3β in
MPP+-intoxicated SH-SY5Y Cells. Dis Markers.
2017(5806146)2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sillivan SE, Jamieson S, de Nijs L, Jones
M, Snidjers C, Klengel T, Joseph NF, Krauskopf J, Kleinjans J and
Vinkers CH: MicroRNA regulation of persistent stress-enhanced
memory. Mol Psychiatry: May 29, 2019 (Epub ahead of print).
|
|
18
|
Jiang B, Ball RL, Michel P, Jovin T, Desai
M, Eskandari A, Naqvi Z and Wintermark M: Prevalence of imaging
biomarkers to guide the planning of acute stroke reperfusion
trials. Stroke. 48:1675–1677. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kwah LK and Diong J: National Institutes
of Health Stroke Scale (NIHSS). J Physiother. 60(61)2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT Method. Methods.
25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yang X, Liu Y, Liu C, Xie W, Huang E,
Huang W, Wang J, Chen L, Wang H, Qiu P, et al: Inhibition of ROCK2
expression protects against methamphetamine-induced neurotoxicity
in PC12 cells. Brain Res. 1533:16–25. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Rong F, Gao X, Liu K and Wu J:
Methotrexate remediates spinal cord injury in vivo and in
vitro via suppression of endoplasmic reticulum stress-induced
apoptosis. Exp Ther Med. 15:4191–4198. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Xiang W, Tian C, Lin J, Wu X, Pang G, Zhou
L, Pan S and Deng Z: Plasma let-7i and miR-15a expression are
associated with the effect of recombinant tissue plasminogen
activator treatment in acute ischemic stroke patients. Thromb Res.
158:121–125. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhao B, Zhu Z, Hao J, Wan Z and Guo X:
Decreased plasma miR-335 expression in patients with acute ischemic
stroke and its association with calmodulin expression. J Int Med
Res. 44:1331–1338. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhou J, Chen L, Chen B, Huang S, Zeng C,
Wu H, Chen C and Long F: Increased serum exosomal miR-134
expression in the acute ischemic stroke patients. BMC Neurol.
18(198)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ko Y, Lee S, Chung JW, Han MK, Park JM,
Kang K, Park TH, Park SS, Cho YJ, Hong KS, et al: MRI-based
algorithm for acute ischemic stroke subtype classification. J
Stroke. 16:161–172. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Shi FP, Wang XH, Zhang HX, Shang MM, Liu
XX, Sun HM and Song YP: MiR-103 regulates the angiogenesis of
ischemic stroke rats by targeting vascular endothelial growth
factor (VEGF). Iran J Basic Med Sci. 21:318–324. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yao S, Tang B, Li G, Fan R and Cao F:
miR-455 inhibits neuronal cell death by targeting TRAF3 in cerebral
ischemic stroke. Neuropsychiatr Dis Treat. 12:3083–3092.
2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang J, Lin M, Ren H, Yu Z, Guo T and Gu
B: Expression and clinical significance of serum miR-497 in
patients with acute cerebral infarction. Clin Lab.
65(65)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cojocaru IM, Cojocaru M, Tănăsescu R,
Iliescu I, Dumitrescu L and Silosi I: Expression of IL-6 activity
in patients with acute ischemic stroke. Rom J Intern Med.
47:393–396. 2009.PubMed/NCBI
|
|
31
|
Kwan J, Horsfield G, Bryant T, Gawne-Cain
M, Durward G, Byrne CD and Englyst NA: IL-6 is a predictive
biomarker for stroke associated infection and future mortality in
the elderly after an ischemic stroke. Exp Gerontol. 48:960–965.
2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Griesi-Oliveira K, Acab A, Gupta AR,
Sunaga DY, Chailangkarn T, Nicol X, Nunez Y, Walker MF, Murdoch JD,
Sanders SJ, et al: Modeling non-syndromic autism and the impact of
TRPC6 disruption in human neurons. Mol Psychiatry. 20:1350–1365.
2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li W, Yang F, Gao J, Tang Y, Wang J and
Pan Y: Over-expression of TRPC6 via CRISPR based synergistic
activation mediator in BMSCs ameliorates brain injury in a rat
model of cerebral ischemia/reperfusion. Neuroscience. 415:147–160.
2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Li H, Huang J, Du W, Jia C, Yao H and Wang
Y: TRPC6 inhibited NMDA receptor activities and protected neurons
from ischemic excitotoxicity. J Neurochem. 123:1010–1018.
2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Du W, Huang J, Yao H, Zhou K, Duan B and
Wang Y: Inhibition of TRPC6 degradation suppresses ischemic brain
damage in rats. J Clin Invest. 120:3480–3492. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
36
|
Guo C, Ma Y, Ma S, Mu F, Deng J, Duan J,
Xiong L, Yin Y, Wang Y, Xi M, et al: The role of TRPC6 in the
neuroprotection of calycosin against cerebral ischemic injury. Sci
Rep. 7(3039)2017.PubMed/NCBI View Article : Google Scholar
|
